Companies / BOC Sciences / Perakizumab
BOC Sciences

Perakizumab | BOC Sciences

Perakizumab is a humanized IgG1_ monoclonal antibody directed against IL-17A. Perakizumab acts as an immunomodulator with the potential for the treatment of autoimmune diseases including psoriatic arthritis.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.